AlloantibodyDependent Pathways in Allograft Rejection - PowerPoint PPT Presentation

1 / 33
About This Presentation
Title:

AlloantibodyDependent Pathways in Allograft Rejection

Description:

Contribution of Anti-MHC antibodies to graft rejection and activation of EC ... Activation of P13K/Akt signaling pathway and regulation of apoptotic genes (Bad, ... – PowerPoint PPT presentation

Number of Views:48
Avg rating:3.0/5.0
Slides: 34
Provided by: barbaraw9
Category:

less

Transcript and Presenter's Notes

Title: AlloantibodyDependent Pathways in Allograft Rejection


1
Alloantibody-Mediated Rejection Complement and
non-Complement Dependent Mechanisms
B.A. Wasowska
JHMI
2
Specific recognition of MHC Antibodies
Complement independent
Macrophage
cytokines
FcR
Endothelial cells
3
Specific recognition of MHC Antibodies
Complement dependent
Complement independent
cytokines
Macrophage
Macrophage
cytokines
CRs
FcR
C4
C3
Endothelial cells
4
Experimental Design
Heart donors Recipients Incompatibilities
B10.A C57BL/6 H-2, H-9 IgKO
(m-/m-) passively transferred with mAbs C
activation IgG2b yes IgG1 no IgG2bIgG1 yes

5
Passive Transfer of IgG1 and IgG2b to IgKO
Recipients of Cardiac Allografts
6
Passive Transfer of IgG1 and IgG2b to IgKO
Recipients of Cardiac Allografts
7
Pro-Inflammatory Effects of anti-MHC Antibodies
in the Absence of Complement
Anti-MHC Ab
Endothelial Cells
8
Contribution of Anti-MHC antibodies to graft
rejection and activation of EC
  • Ligation of MHC class I molecules with anti-MHC
    antibodies on EC and smooth muscle results in
  • Increased phosphorylation of intracellualr
    proteins and induction of fibroblast growth
    factor receptor on EC. (Bian, Reed. JI, 1999,
    163 1010).
  • Increased phosphorylation of Src, Paxillin and
    Focal Adhesion Kinase and enhanced proliferation
    to fibroblast growth factor. (Jin,Reed. JI,
    2002, 168 5415).
  • Activation of P13K/Akt signaling pathway and
    regulation of apoptotic genes (Bad, Bcl-2 and
    Bcl-xL). (Jin, Fishbein,...Reed, Human Immunol.
    2004, 65 291).

9
Experimental Design EC Activation in vitro
Methods Addition of different IgG subclasses to
mouse endothelial cell line SVEC4-10
Measurement cytokine production by EC in 48 hr
cultures
10
Cytokine Array on Culture Supernatants
Endothelial Cells Stimulated by IgG1 IgG2b
11
What Effects Do Antibodies Have on Endothelial
Cells and Leukocytes in the Absence of Complement?
?
12
Cytokine Array on Culture Supernatants
Endothelial Cells Stimulated by IgG1 IgG2b
Peritoneal and Endothelial Cells Stimulated by
IgG1 IgG2b
13
ELISA for MCP-1 and IL-6 in Cultures of
Endothelial Cells Peritoneal Cells
14
ELISA for MCP-1 and IL-6 in Cultures of
Endothelial Cells Alloantigen-primed SPL from
Heart Recipient
15
What Effects Do Antibodies Have on FcgR Cells
in the Absence of Complement ?
Macrophages
?
FcgR
?
Endothelial Cells
16
Possible Involvement of FcgR III in IgG1-Mediated
Cell Activation in the Absence of Complement
WT and FcgR III KO C57BL/6 splenocytes and lymph
node lymphocytes primed in vivo by 10-day
exposure to B10.A skin transplant were
co-cultured with mouse endothelial cells in the
presence of IgG1 Ab-s.
17
The Affinity of Mouse FcgRs to Bind IgG Subclasses
18
ELISA for IL-6 in Cultures of Endothelial Cells
IgG1 Lymph Node Cells from WT and FcgRIII KO
19
ELISA for MCP-1 in Cultures of Endothelial Cells
IgG1 Lymph Node Cells from WT and FcgRIII KO
20
SUMMARY
  • There is effective interaction between mouse
    endothelial cells, alloantibodies and
    alloantigen-primed effector cells.
  • FcgR III participates in IgG1-mediated activation
    of mouse effector cells.

21
What Effects Do Antibodies Have on Human
Endothelial Cells and Human FcgRI Cells?
U 937
Anti-MHC Ab W6/32 (IgG2a)
?
FcgRI
BMEC
22
The affinity of human FcgRs to bind mouse IgG
subclasses
23
Expression of CD 64 (FcgRI) on U-937 Macrophages
after Stimulation with IFN-g
24
ELISA for MCP-1 and IL-6 in Cultures of Human
BMEC anti-HLA Ab (IgG2a) IFN-g-Stimulated
U-937 Macrophages
25
SUMMARY
  • Two lines of evidence, in mouse and human models
    of EC sensitized with anti-MHC antibodies,
    suggest that
  • FcgR participate in IgG-mediated activation of
    EC.

26
Specific recognition of MHC Antibodies
Complement independent
Macrophage
cytokines
FcR
Endothelial cells
27
Specific recognition of MHC Antibodies
Complement dependent
Complement independent
cytokines
Macrophages
Macrophages
cytokines
CRs
FcR
C4
C3
Endothelial cells
28
Complement Receptors for C4 and C3
29
Possible Interactions of iC3b and C3b with CR3 in
IgG1IgG2b-Mediated Cell Activation in the
Presence of Complement
WT and CR3 KO C57BL/6 peritoneal macrophages were
co-cultured with mouse endothelial cells in the
presence of IgG1Ig2b mAb-s Complement.
30
ELISA for MCP-1 and IL-6 in Cultures of
Endothelial Cells IgG1IgG2b C Macrophages
from WT and CR3 KO
31
Other Complement Receptors
32
Complement and non-Complement Dependent
Mechanisms Contribute to Alloantibody-Mediated
Activation of Endothelial Cells and Macrophages
33
ACKNOWLEDGEMENTS
  • Zhiping Qian, M.D. Wink Baldwin, M.D., Ph.D.
  • Salma Rahimi Millie Samaniego, M.D.
  • Mike Coonfield
  • Justin Garyu
  • Jinhuan Liu
  • Karen Fox
  • Miriam Reynolds
Write a Comment
User Comments (0)
About PowerShow.com